Successful thalidomide treatment of adult solitary perianal Langerhans cell histiocytosis

European Journal of Dermatology

Volumn 20, Issue 3, 2010, Pages 391-392

  Li, Ruohong ^a   Lin, Tong ^a   Gu, Heng ^a   Zhou, Zhanchao ^a  

^a INSTITUTE OF DERMATOLOGY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ETHACRIDINE; POVIDONE IODINE; THALIDOMIDE; ZINC OXIDE;

ADULT; ANAMNESIS; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; DRUG DOSE REDUCTION; HISTIOCYTOSIS X; HUMAN; LABORATORY TEST; LETTER; MALE; PHYSICAL EXAMINATION; SKIN BIOPSY; THORAX RADIOGRAPHY; ULTRASOUND;

ADMINISTRATION, ORAL; ADULT; DIAGNOSIS, DIFFERENTIAL; DOSE-RESPONSE RELATIONSHIP, DRUG; FOLLOW-UP STUDIES; HISTIOCYTOSIS, LANGERHANS-CELL; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MALE; SKIN DISEASES; THALIDOMIDE;

EID: 77952868332     PISSN: 11671122     EISSN: 19524013     Source Type: Journal    
DOI: 10.1684/ejd.2010.0905     Document Type: Letter

References (6)

1. Field M, Inston N, Muzaffar S, et al. Perianal langerhans cell histiocytosis. Int J Colorectal Dis 2007; 22: 1141-1142
2. Santillan A, Montero AJ, Kavanagh JJ, et al. Vulvar Langerhans cell histiocytosis: a case report and review of the literature. Gynecol Oncol 2003; 91: 241-246 (Pubitemid 37188618)
3. Caux C, Dezutter-Dambuyant C, Schmitt D, et al. GM-CSF and TNF-alpha cooperate in the generation of dendritic Langerhans cells. Nature 1992; 360: 258-261
4. Moreira AL, Sampaio EP, Zmuidzinas A, et al. Thalidomide exerts its inhibitory action on tumor necrosis factor a by enhancing mRNA degradation. J Exp Med 1993; 177: 1675-1680 (Pubitemid 23146134)
5. McClain KL, Kozinetz CA. A phase II trial using thalidomide for langerhans cell histiocytosis. Pediatr Blood Cancer 2007; 48: 44-49 (Pubitemid 44871592)
6. Wollina U, Kaatz M, Krönert C, et al. Cutaneous langerhans cell histiiocytosis with subsequent development of haematological malignancies. Report of two cases. Acta Dermatovenerol Alp Panonica Adriat 2006; 15: 79-84.